International Society of Antimicrobial Chemotherapy (ISAC) Information

The International Society of Antimicrobial Chemotherapy (ISAC) aims to advance the education and the science of therapy of infection through the establishment of an international federation of affiliated national and regional societies with similar aims and objectives to its own. ISAC currently has a worldwide membership composed of 86 national and regional societies, which in turn have over 50,000 individual members. ISAC promotes the conduct of scientific research, convening international congresses, conferences and symposia and encourages co-operation within the society and between scientists belonging to other societies dealing with related basic and clinical sciences. In the last decade, most of the Society's work has been on antimicrobials. ISAC currently has 24 Working Groups and actively encourages and/or sponsors the formation of international working groups for special research, training projects or the use of therapeutics in the field of anti-infective and anti-neoplastic therapy and coordinating their activities. The Working Groups contribute significantly to the ISAC Disease Management Series of meetings. In addition, the ISAC awards scholarships and bursaries to enable attendance at and travel to its international biennial congresses. The Society’s official journals are the International Journal of Antimicrobial Agents and Chemotherapy (IJAA) and the Journal of Global Antimicrobial Resistance (JGAR).